Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
AJEM traveled to Berlin, Germany to bring you the latest research on psychedelic medicine at the MIND Foundation’s INSIGHT 2023 conference. Researchers from all over the world convened to present novel findings showing the promise of psychedelic medicine to treat a range of conditions ranging from depression and PTSD, alcoholism to Alzheimer disease’s and, from long COVID to Lyme disease.
Dr. Matthew Johnson, a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine in Baltimore. Dr. Johnson, considered a pioneer in the use of psychedelic medicine to treat smoking, depression, cancer distress, and other indications, spoke at the Insight 2023 conference in Berlin.
Credit: Larry Luxner.
Occulus installation, which is supposed to resemble a human eye, on display at INSIGHT 2023 in Berlin.
Credit: Larry Luxner.
Prof. John Skerritt, Australia’s former Deputy Minister of Health, oversaw the regulation of psychedelic therapy as medicine. He spoke about the Australian experience at the Insight 2023 conference in Berlin.
Credit: Larry Luxner.
Psychedelic experience underway at Insight 2023 in Berlin.
Credit: Larry Luxner.
Headline from a 2016 issue of the New York Times, shown at the Insight 2023 conference in Berlin, demonstrates the evolving fascination with psychedelic medicine.
Credit: Larry Luxner.
Albert Garcia-Romeu, PhD, with his poster presentation on using psilocybin to treat athlete concussion at the Insight 2023 conference in Berlin.
Credit: Larry Luxner.
Psilocybin test kit for magic mushrooms are given out at the Insight 2023 psychedelic conference in Berlin.
Credit: Larry Luxner.
Psychedelic consulting services offered at Insight 2023 in Berlin.
Credit: Larry Luxner.
Hanna Douglass, M Sc, of Imperial College London’s Centre for Psychedelic Research, presents her study on psilocybin to treat anorexia at the Insight 2023 conference in Berlin.
Credit: Larry Luxner.
Frederico Magalhaes, a psychiatrist and clinical research fellow at Britain’s Imperial College Centre for Psychedelic Research, presents a study on psilocybin to treat anorexia at the Insight 2023 conference in Berlin.
Poster presentation at Insight 2023 in Berlin: Potential analgesic effects of psychedelics on select chronic pain conditions.
Credit: Larry Luxner.
Psychedelic art for sale at Insight 2023 in Berlin.
Credit: Larry Luxner.
Highly tattooed conference delegate during coffee break at Insight 2023, Berlin.
Credit: Larry Luxner.
Delegates in Berlin go over the Insight 2023 conference program agenda.
Credit: Larry Luxner.
Poster presentation at Insight 2023 in Berlin: Ibogaine restores control over compulsive alcohol drinking in addicted rats.
Credit: Larry Luxner.
Manvir Singh, an anthropologist with the University of California-Davis, is an expert on the use of psychedelic medicine in indigenous culture. He spoke at the Insight 2023 conference in Berlin.
Credit: Larry Luxner.
Poster presentation at Insight 2023 in Berlin: Exploring neurobiological mechanisms and subjective effects of ketamine in problematic gambling.
Credit: Larry Luxner.
Delegates listen to opening remarks at the Insight 2023 psychedelic conference in Berlin.
Credit: Larry Luxner.
